Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host–Microbial Biological Systems describes the dynamic relationships between a host (any living organism) and the microbial communities (microbiota) that live in or on it. These interactions encompass parasitic, mutualistic, and commensal relationships and play essential roles in host immunity, metabolism, neurological function, disease susceptibility, and homeostasis[1][2][3][5][6]. The system is defined by its complexity and mutual influence, involving metabolic, immune, and signaling communications. It cannot be classified as a specific receptor, enzyme, transporter, or other canonical drug target, but rather as a subject of systems biology research integral to understanding health and disease states. While these systems are not directly targeted by drugs as a single entity, manipulating the microbiota (via antibiotics, probiotics, diet, or fecal transplants) can indirectly affect host health and disease outcomes[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host–Microbial Biological System.